Re: Can Hepalink afford US rights? and ROFR
|
5
|
Resverlogix Corp.
|
Feb 04, 2019 04:17PM
|
Re: You're right 10bagr, you didn't sway me....
|
3
|
Resverlogix Corp.
|
Feb 01, 2019 09:10AM
|
Re: You're right 10bagr, you didn't sway me....
|
4
|
Resverlogix Corp.
|
Feb 01, 2019 08:47AM
|
Re: You're right 10bagr, you didn't sway me....
|
8
|
Resverlogix Corp.
|
Jan 31, 2019 11:53PM
|
Re: Hopefully we get news after the bell or before tomorrow's open
|
4
|
Resverlogix Corp.
|
Jan 30, 2019 02:48PM
|
Re: The waiting game.....Jan 30th = max pain :-)
|
3
|
Resverlogix Corp.
|
Jan 24, 2019 05:20PM
|
Re: 250 MACE scenario question
|
3
|
Resverlogix Corp.
|
Jan 24, 2019 05:11PM
|
Re: 250 MACE scenario question
|
4
|
Resverlogix Corp.
|
Jan 23, 2019 07:27PM
|
Re: RVX-297 vs RVX-208 for autoimmune indications
|
2
|
Resverlogix Corp.
|
Jan 08, 2019 09:50AM
|
Re: Adjudication
|
2
|
Resverlogix Corp.
|
Dec 28, 2018 11:02PM
|
Re: Adjudication
|
3
|
Resverlogix Corp.
|
Dec 28, 2018 04:15PM
|
Re: "top line data on or before January 31, 2019" A Covenant of the loan
|
4
|
Resverlogix Corp.
|
Dec 19, 2018 06:13PM
|
Re: The HDL hypothesis lives on
|
5
|
Resverlogix Corp.
|
Dec 18, 2018 08:16PM
|
Re: "top line data on or before January 31, 2019" A Covenant of the loan
|
3
|
Resverlogix Corp.
|
Dec 18, 2018 06:07PM
|
Bio Europe slide deck
|
5
|
Zenith Epigenetics
|
Dec 06, 2018 02:16AM
|
Re: Why such little intrest, so close to the finis
|
10
|
Resverlogix Corp.
|
Nov 17, 2018 08:32AM
|
Re: Clovis' Rubracra
|
7
|
Zenith Epigenetics
|
Oct 05, 2018 12:12PM
|
Re: Clovis' Rubracra
|
6
|
Zenith Epigenetics
|
Oct 05, 2018 11:45AM
|
Re: I'm glad the SSRA issue has finally been put to bed....
|
6
|
Resverlogix Corp.
|
Sep 19, 2018 08:27AM
|
New RVX Investor
|
8
|
Resverlogix Corp.
|
Sep 13, 2018 09:03PM
|